INTERNATIONAL PATENT: SHANGHAI HUILUN PHARMACEUTICAL CO., LTD., 上海汇伦医药股份有限公司 FILES APPLICATION FOR "NOVEL SODIUM CHANNEL MODULATOR COMPOUND AND USE THEREOF"

GENEVA, Aug. 10 -- SHANGHAI HUILUN PHARMACEUTICAL CO., LTD. (10th Floor, Building 5, No. 525 Yuanjiang RoadMinhang District, Shanghai 200241), 上海汇伦医药股份有限公司 (中国上海市闵行区元江路525号5幢10层) filed a patent application (PCT/CN2025/074442) for "NOVEL SODIUM CHANNEL MODULATOR COMPOUND AND USE THEREOF" on Jan 23, 2025. With publication no. WO/2025/162194, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual...